Biophytis S.A. Releases 2024 Financial Results
| Field | Detail |
|---|---|
| Company | Biophytis SA |
| Form Type | 6-K |
| Filed Date | Jul 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, reporting
TL;DR
Biophytis dropped its 2024 financials on July 11th.
AI Summary
Biophytis S.A. announced on July 11, 2025, the publication of its 2024 financial results. The company, headquartered in Paris, France, is involved in the pharmaceutical preparations industry.
Why It Matters
This filing provides investors with the company's financial performance for the fiscal year 2024, which is crucial for assessing its current financial health and future prospects.
Risk Assessment
Risk Level: low — This is a routine financial results announcement and does not contain significant new risks.
Key Players & Entities
- Biophytis S.A. (company) — Registrant
- July 11, 2025 (date) — Date of report and announcement
- Stanislas Veillet (person) — Contact person
- Paris, France (location) — Company headquarters
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report the publication of Biophytis S.A.'s 2024 financial results.
When did Biophytis S.A. announce its 2024 financial results?
Biophytis S.A. announced its 2024 financial results on July 11, 2025.
Where is Biophytis S.A. headquartered?
Biophytis S.A. is headquartered in Paris, France.
What is the Commission File Number for Biophytis S.A.?
The Commission File Number for Biophytis S.A. is 001-38974.
What industry is Biophytis S.A. classified under?
Biophytis S.A. is classified under the Pharmaceutical Preparations industry (SIC code 2834).
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 11, 2025 by Stanislas Veillet regarding Biophytis SA.